[ad_1]
As part of our new promotion, annual SIGNATURE subscriptions purchased between March 31 and April 9 can now be purchased at a 40% discount for HUF 18,000. This gives you access to the latest news, key analysis, and exclusive content at a much better price. Plus, you can even support the production of quality inexpensive content. Click here for more details.
Emergent BioSolution pharmaceutical plant in Baltimore revealed the need to replace raw material on April 1 after one of the manufacturer’s shipments stopped during quality control.
The government feared that the incident would erode confidence in the two vaccines, so it decided that from now on only the American J&J vaccines would be produced there. British-Swedish company AstraZeneca is in talks with the US government to find new production capacity.
Unlike the vaccine, developed jointly by AstraZeneca and the University of Oxford, the Janssen vaccine consists of a single dose and has been approved for a third emergency use in the United States. The AstraZeneca vaccine has not yet been approved.
Cover Image Source: Rafael Henrique / SOPA Images / LightRocket via Getty Images
[ad_2]
